These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28638484)

  • 1. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery
    Zhu X; Tao W; Liu D; Wu J; Guo Z; Ji X; Bharwani Z; Zhao L; Zhao X; Farokhzad OC; Shi J
    Theranostics; 2017; 7(7):1990-2002. PubMed ID: 28638484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
    Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
    J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic Mucic Acid Polymer-Based siRNA Delivery Systems.
    Pan DW; Davis ME
    Bioconjug Chem; 2015 Aug; 26(8):1791-803. PubMed ID: 26154102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
    Müller K; Kessel E; Klein PM; Höhn M; Wagner E
    Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing.
    Wang Y; Malcolm DW; Benoit DSW
    Biomaterials; 2017 Sep; 139():127-138. PubMed ID: 28601703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
    Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
    Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
    Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
    Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
    Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
    Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.
    Wang Y; Zhang S; Benoit DSW
    J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic Domain Structure of Linear-Dendritic Poly(ethylene glycol) Lipids Affects RNA Delivery of Lipid Nanoparticles.
    Zhou K; Johnson LT; Xiong H; Barrios S; Minnig JT; Yan Y; Abram B; Yu X; Siegwart DJ
    Mol Pharm; 2020 May; 17(5):1575-1585. PubMed ID: 32267707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.